The EASD Annual Meeting 2024 has come to a close but the Vitual Meeting platform remains open until 11 October 2024
The Virtual Meeting platform gives registed delegates exclusive access to presentation recordings and e-posters from EASD 2024. Take advantage to catch up on any content you may have missed or explore topics in greater depth. You can still earn CME credits by following the recordings and claim them starting 14 October 2024.
EASD 2024 - Impressions and Highlights from Madrid
What an incredible week! Thank you all for making the 60th anniversary of the EASD Annual Meeting such an amazing event, both in Madrid and online!
Watch our highlight video to feel the buzz with over 12,300 participants joining us for exchange, networking and sharing the latest advances in diabetes research and care. We already look forward to welcoming you next year in Vienna for EASD 2025.
Show the world that you've joined us for EASD 2024
Share your picture and leave a message. Together, we will promote excellence in diabetes care through research, networking and education.
The EASD 2024 picture mosaic is handled by INTERPLAN Congress, Meeting & Event Management AG and sponsored by Abbott.
EFSD welcomes applications for the following diabetes research programme
EFSD and Novo Nordisk A/S Programme for Diabetes Research in Europe
Application Deadline: 3 February 2025
Programme accepting applications from all fields of diabetes research including both basic and clinical research.
The European Foundation for the Study of Diabetes (EFSD) was created by EASD to provide funding in all areas of diabetes research across the entire European Region. The aims of EFSD are to encourage and support groundbreaking diabetes research and to promote the next generation of leading diabetes researchers.
Diabetologia is the Journal of the EASD and publishes original clinical, translational and experimental research within the field of diabetes. We are interested in papers that convey new information or insight into any aspect of the condition, ranging from basic science to clinical applications.
